tiprankstipranks
Trending News
More News >
Tvardi Therapeutics (TVRD)
NASDAQ:TVRD
US Market

Tvardi Therapeutics (TVRD) Technical Analysis

Compare
2,286 Followers

Technical Sentiment

Overall Consensus
Strong Buy
15Bullish
6Neutral
1Bearish
Technical Analysis Consensus
Buy
3Bullish
6Neutral
1Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Tvardi Therapeutics’s (TVRD) Moving Averages Convergence Divergence (MACD) indicator is 0.87, suggesting Tvardi Therapeutics is a Sell.
Tvardi Therapeutics’s (TVRD) 20-Day exponential moving average is 16.77, while Tvardi Therapeutics’s (TVRD) share price is $18.85, making it a Buy.
Tvardi Therapeutics’s (TVRD) 50-Day exponential moving average is 15.79, while Tvardi Therapeutics’s (TVRD) share price is $18.85, making it a Buy.

Tvardi Therapeutics (TVRD) Pivot Points

Apr 26, 2025, 01:38 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
14.42
15.51
16.66
17.75
18.90
19.99
21.14
Fibonacci
15.51
16.37
16.90
17.75
18.61
19.14
19.99
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Tvardi Therapeutics (TVRD) Moving Averages

Apr 26, 2025, 01:38 PM
Period
Simple
Exponential
MA5
18.42Buy
18.24Buy
MA10
17.47Buy
17.58Buy
MA20
16.14Buy
16.77Buy
MA50
15.61Buy
15.79Buy
MA100
14.59Buy
14.99Buy
MA200
12.92Buy
14.74Buy
Tvardi Therapeutics’s (TVRD) 10-Day exponential moving average is 17.58, while Tvardi Therapeutics’s (TVRD) share price is $18.85, making it a Buy.
Tvardi Therapeutics’s (TVRD) 100-Day exponential moving average is 14.99, while Tvardi Therapeutics’s (TVRD) share price is $18.85, making it a Buy.
Tvardi Therapeutics’s (TVRD) stock price is $18.85 and Tvardi Therapeutics’s (TVRD) 50-day simple moving average is 15.61, creating a Buy signal.
Tvardi Therapeutics’s (TVRD) stock price is $18.85 and Tvardi Therapeutics’s (TVRD) 100-day simple moving average is 14.59, creating a Buy signal.
Tvardi Therapeutics’s (TVRD) stock price is $18.85 and Tvardi Therapeutics’s (TVRD) 200-day simple moving average is 12.92, creating a Buy signal.

Tvardi Therapeutics (TVRD) Technical Indicators

Apr 26, 2025, 01:38 PM
Name
Value
Implied Action
RSI (14)
61.97
Neutral
STOCH (9,6)
35.78
Neutral
STOCHRSI (14)
40.23
Neutral
MACD (12,26)
0.87
Sell
ADX (14)
36.74
Neutral
Williams %R
-55.81
Buy
CCI (14)
89.28
Neutral
ATR (14)
2.00
-
Ultimate Oscillator
44.85
Neutral
ROC
30.90
Buy
Tvardi Therapeutics’s (TVRD) Relative Strength Index (RSI) is 61.97, creating a Neutral signal.
Tvardi Therapeutics’s (TVRD) Trend Strength Indicator (ADX) is 36.74, creating a Neutral signal.
Tvardi Therapeutics’s (TVRD) Commodity Channel Index (CCI) is 89.28, creating a Neutral signal.
Tvardi Therapeutics’s (TVRD) Price Rate of Change (ROC) is 30.90, creating a Buy signal.

FAQ

Is TVRD a Buy, Hold, or Sell?
Based on TVRD’s technical indicators, TVRD is a Strong Buy.
    What is TVRD’s RSI (14)?
    TVRD’s RSI (14) is 61.97, which suggests TVRD is a Neutral.
      What is TVRD’s MACD?
      TVRD’s MACD is 0.87, which suggests TVRD is a Sell.
        What is TVRD’s 5-day moving average?
        TVRD’s 5-day moving average is 18.42, which suggests TVRD is a Buy.
          What is TVRD’s 20-day moving average?
          TVRD 20-day moving average is 16.14, which suggests TVRD is a Buy.
            What is TVRD’s 50-day moving average?
            TVRD’s 50-day moving average is 15.61, which suggests TVRD is a Buy.
              What is TVRD’s 200-day moving average?
              TVRD’s 200-day moving average is 12.92, which suggests TVRD is a Buy.
                What is TVRD’s Williams % R (14)?
                TVRD’s Williams % R (14) is -55.81, which suggests TVRD is a Buy.
                  What is TVRD’s CCI (14)?
                  TVRD’s CCI (14) is 89.28, which suggests TVRD is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis